Coupang Other Non-Current Liabilities decreased by 11.3% to $430.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 2.3%, from $440.00M to $430.00M. Over 4 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows an upward trend with a 37.6% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q2 '21 | Q3 '21 | Q4 '22 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $159.68M | $169.49M | $337.00M | $403.00M | $431.00M | $459.00M | $423.00M | $443.00M | $465.00M | $443.00M | $440.00M | $467.00M | $541.00M | $485.00M | $430.00M |
| QoQ Change | — | +6.1% | +98.8% | +19.6% | +6.9% | +6.5% | -7.8% | +4.7% | +5.0% | -4.7% | -0.7% | +6.1% | +15.8% | -10.4% | -11.3% |
| YoY Change | — | — | — | — | — | +36.2% | — | +9.9% | +7.9% | -3.5% | +4.0% | +5.4% | +16.3% | +9.5% | -2.3% |